Search for an ETF or holding
NUREXONE BIOLOGIC INC (NRX.V) is a Canadian company in the healthcare sector, listed on TSXV. Market capitalization of 55 million CAD (micro-cap).
NurExone Biologic Inc., a pharmaceutical technology company, develops a platform for biologically guided exosome-based therapies for the treatment of central nervous system injuries. It offers ExoPTEN, for treatment of acute spinal cord injuries. The company was founded in 2020 and is based in Toronto, Canada.